Cargando…
Inhaled nitric oxide and cognition in pediatric severe malaria: A randomized double-blind placebo controlled trial
BACKGROUND: Severe malaria is a leading cause of acquired neurodisability in Africa and is associated with reduced nitric oxide (NO) bioavailability. A neuroprotective role for inhaled NO has been reported in animal studies, and administration of inhaled NO in preterm neonates with respiratory distr...
Autores principales: | Bangirana, Paul, Conroy, Andrea L., Opoka, Robert O., Hawkes, Michael T., Hermann, Laura, Miller, Christopher, Namasopo, Sophie, Liles, W. Conrad, John, Chandy C., Kain, Kevin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784958/ https://www.ncbi.nlm.nih.gov/pubmed/29370261 http://dx.doi.org/10.1371/journal.pone.0191550 |
Ejemplares similares
-
Inhaled nitric oxide for the adjunctive therapy of severe malaria: Protocol for a randomized controlled trial
por: Hawkes, Michael, et al.
Publicado: (2011) -
Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trial
por: Hawkes, Michael T., et al.
Publicado: (2015) -
Methemoglobin and nitric oxide therapy in Ugandan children hospitalized for febrile illness: results from a prospective cohort study and randomized double-blind placebo-controlled trial
por: Conroy, Andrea L., et al.
Publicado: (2016) -
Prospective validation of pediatric disease severity scores to predict mortality in Ugandan children presenting with malaria and non-malaria febrile illness
por: Conroy, Andrea L, et al.
Publicado: (2015) -
Use of a three-band HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children
por: Hawkes, Michael, et al.
Publicado: (2014)